A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Summary

The aim of this study is to investigate the safety and efficacy of the prophylactic use of Trilaciclib in patients with non-small cell lung cancer (NSCLC) receiving platinum-based chemotherapy, so as to provide more evidence-based medical evidence for the optimal diagnosis and treatment strategy in this population.

Timeline

Start

2023-08-10

Primary completion

2025-02-10

Completion

2025-08-10

Drugs

Indications